Insight Molecular Diagnostics (IMDX) Asset Utilization Ratio (2020 - 2026)
Insight Molecular Diagnostics (IMDX) posted Asset Utilization Ratio of 0.06 for Q1 2026, down 49.39% sequentially from 0.12 in Q4 2025, and down 26.86% YoY from 0.08 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
Insight Molecular Diagnostics has reported Asset Utilization Ratio for 7 years, with the latest figure at 0.06 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 26.86% year-over-year to 0.06 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.06 (down 26.86% YoY) and the FY2025 annual result came in at 0.13, up 289.69% from the prior year.
- Asset Utilization Ratio retreated to 0.06 in Q1 2026 per IMDX's latest filing, from 0.12 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.12 in Q4 2025 and troughed at 0.01 in Q3 2024.
- A 5-year average of 0.05 and a median of 0.05 in 2022 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio slumped 84.02% in 2024, then surged 852.71% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.04 in 2022, then tumbled by 53.67% to 0.02 in 2023, then soared by 85.98% to 0.04 in 2024, then jumped by 225.71% to 0.12 in 2025, then slumped by 49.39% to 0.06 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.06, 0.12, and 0.09 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 0.41 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 0.29 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 1.33 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 0.56 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 0.57 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 1.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 0.68 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 1.13 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 0.69 |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | 0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.06 |
| Dec 31, 2025 | 0.12 |
| Sep 30, 2025 | 0.09 |
| Jun 30, 2025 | 0.08 |
| Mar 31, 2025 | 0.08 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | 0.06 |
| Jun 30, 2023 | 0.06 |
| Mar 31, 2023 | 0.05 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.05 |
| Dec 31, 2021 | 0.05 |
| Sep 30, 2021 | 0.03 |
| Jun 30, 2021 | 0.03 |